172 related articles for article (PubMed ID: 28381400)
1. Association of Plasma 7-Ketocholesterol With Cardiovascular Outcomes and Total Mortality in Patients With Coronary Artery Disease.
Song J; Wang D; Chen H; Huang X; Zhong Y; Jiang N; Chen C; Xia M
Circ Res; 2017 May; 120(10):1622-1631. PubMed ID: 28381400
[TBL] [Abstract][Full Text] [Related]
2. Plasma 7-ketocholesterol levels and the risk of incident cardiovascular events.
Wang M; Long W; Li D; Wang D; Zhong Y; Mu D; Song J; Xia M
Heart; 2017 Nov; 103(22):1788-1794. PubMed ID: 28490621
[TBL] [Abstract][Full Text] [Related]
3. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
4. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
9. Association of Serum Retinoic Acid With Risk of Mortality in Patients With Coronary Artery Disease.
Liu Y; Chen H; Mu D; Li D; Zhong Y; Jiang N; Zhang Y; Xia M
Circ Res; 2016 Aug; 119(4):557-63. PubMed ID: 27323773
[TBL] [Abstract][Full Text] [Related]
10. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
[TBL] [Abstract][Full Text] [Related]
12. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.
Hsu CY; Tseng WK; Wu YW; Lin TH; Yeh HI; Chang KC; Wang JH; Chou RH; Huang CY; Huang PH; Leu HB; Yin WH; Wu CC; Lin SJ; Chen JW
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1240-1252. PubMed ID: 30943772
[TBL] [Abstract][Full Text] [Related]
13. Multiple marker approach to risk stratification in patients with stable coronary artery disease.
Schnabel RB; Schulz A; Messow CM; Lubos E; Wild PS; Zeller T; Sinning CR; Rupprecht HJ; Bickel C; Peetz D; Cambien F; Kempf T; Wollert KC; Benjamin EJ; Lackner KJ; Münzel TF; Tiret L; Vasan RS; Blankenberg S
Eur Heart J; 2010 Dec; 31(24):3024-31. PubMed ID: 20852293
[TBL] [Abstract][Full Text] [Related]
14. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
Tuñón J; Blanco-Colio L; Cristóbal C; Tarín N; Higueras J; Huelmos A; Alonso J; Egido J; Asensio D; Lorenzo Ó; Mahíllo-Fernández I; Rodríguez-Artalejo F; Farré J; Martín-Ventura JL; López-Bescós L
Am J Cardiol; 2014 Feb; 113(3):434-40. PubMed ID: 24295549
[TBL] [Abstract][Full Text] [Related]
17. N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease.
Tuñón J; Higueras J; Tarín N; Cristóbal C; Lorenzo Ó; Blanco-Colio L; Martín-Ventura JL; Huelmos A; Alonso J; Aceña Á; Pello A; Carda R; Asensio D; Mahíllo-Fernández I; López Bescós L; Egido J; Farré J
PLoS One; 2015; 10(6):e0126741. PubMed ID: 26046344
[TBL] [Abstract][Full Text] [Related]
18. Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.
von Scholten BJ; Reinhard H; Hansen TW; Lindhardt M; Petersen CL; Wiinberg N; Hansen PR; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2015 May; 14():59. PubMed ID: 25990319
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]